Effect of combining aspirin and rivaroxaban on atherosclerosis in mice.
Sign Up to like & getrecommendations! Published in 2022 at "Atherosclerosis"
DOI: 10.1016/j.atherosclerosis.2022.02.010
Abstract: BACKGROUND AND AIMS The platelet inhibitor aspirin reduces inflammation and atherosclerosis in both apolipoprotein E deficient (apoE-/-) mice and low-density lipoprotein receptor deficient (Ldlr-/-) mice. Similarly, the factor Xa inhibitor rivaroxaban reduces atherosclerosis in both… read more here.
Keywords: mice; atherosclerosis; ldlr mice; atherosclerosis mice ... See more keywords